Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

U.S. FDA says it needs more time to decide on Juul, other e-cigarettes

Stock MarketsSep 09, 2021 03:40PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
© Reuters. FILE PHOTO: A woman holds a Juul e-cigarette while walking in New York, U.S., September 27, 2018. REUTERS/Brendan McDermid

By Chris Kirkham and Ankur Banerjee

(Reuters) - The U.S. Food and Drug Administration said on Thursday it needs more time to decide whether e-cigarette maker Juul Labs Inc and other major manufacturers can sell their products in the United States.

The agency had been expected to make a decision by Thursday, a year after Juul and other e-cigarette brands, including British American Tobacco (NYSE:BTI) Plc's Vuse and Imperial Brands (OTC:IMBBY) Plc's Blu, faced a deadline to file applications showing their products provided a net benefit to public health.

A federal judge set a September 2020 deadline for the e-cigarette makers and gave companies a one-year grace period to remain on the market without FDA enforcement, while the agency reviewed applications.

The agency on Thursday said it continues to "work expeditiously on the remaining applications," adding many are "in the final stages of review."

It said products that have not been authorized by the FDA - a category that now includes Juul after the one-year grace period - "are subject to enforcement action at the FDA's discretion."

The agency said it will work "as quickly as possible to provide regulatory certainty" and is prioritizing enforcement of e-cigarette products that have not applied for FDA authorization.

The FDA's scientific review of e-cigarettes will decide whether they are effective in getting smokers to quit and, if so, whether the benefits to smokers outweigh the health damage to new users - including teenagers - who never smoked.


E-cigarettes have operated in a regulatory gray area for years. The products, which vaporize a nicotine-laced liquid, have been available in the United States since at least 2007, but the FDA did not formally get jurisdiction over the industry until May 2016.

During that time, Juul and dozens of competitors introduced products that were grandfathered into the market because they were already being sold before the regulation took effect.

The 2016 rule required e-cigarette makers to file extensive applications to the FDA by August 2018 demonstrating the public health benefits of their products, along with data on potential toxins.

Under the administration of Donald Trump, the FDA pushed back the application date to 2022, but public health groups sued in federal court and succeeded in getting the deadline moved up to last year.

In June, FDA acting Commissioner Dr. Janet Woodcock told a congressional panel the agency had received applications for 6.5 million products from more than 550 companies, and said reviewing all submissions by Sept. 9 "will be challenging."

In August, the agency denied marketing applications for nearly 55,000 flavored e-cigarette products from three small companies for failing to provide evidence they appropriately protect public health. The FDA has so far denied applications from more than 100 companies, but has not made a decision on Juul or other major tobacco industry players.

Teenage use of e-cigarettes has surged in recent years, a trend that largely coincided with the rise in popularity of Juul in 2017 and 2018. E-cigarette use among high school students grew from 11.7% in 2017 to 27.5% in 2019, before declining to 19.6% last year, according to a federal survey.

A Reuters investigation in 2019 detailed how Juul’s developers used tobacco industry research and patents to formulate a smooth but potent blend of liquid nicotine that became a key factor in its popularity among teenagers. (

Facing a backlash from parents, teachers and regulators, including state attorneys general, Juul stopped selling its popular fruit- and mint-flavored nicotine pods in 2019, ahead of an FDA ban on such flavors in early 2020.

Over the last two years, Juul has tried to repair its relationship with regulators and the public by taking a lower profile. It stopped print, TV and online advertising in 2019, and pulled back on its international expansion plans to focus on winning regulatory approval in the United States.

Federal survey data from last year showed that Juul’s popularity among teenagers declined significantly from 2019, but was offset by increases in teenage use of other brands. Juul was still the most popular brand among teenagers, according to the survey.

U.S. FDA says it needs more time to decide on Juul, other e-cigarettes

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Felipe Daniel
Felipe Daniel Sep 09, 2021 5:22PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Unless is vaccines the FDA looked the other way rushed to market
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email